Valuation: Ipca Laboratories Limited

Market Cap 476B 4.95B 4.33B 3.99B 3.67B 6.96B 7.07B 47.68B 18.71B 233B 18.6B 18.19B 803B P/E 2027 *
34.1x
P/E 2028 * 28.6x
Enterprise Value 465B 4.83B 4.22B 3.89B 3.58B 6.78B 6.9B 46.49B 18.24B 227B 18.13B 17.74B 783B EV / Sales 2027 *
4.31x
EV / Sales 2028 * 3.77x
Free-Float
54.92%
Yield 2027 *
0.31%
Yield 2028 * 0.33%
1 day+0.65%
1 week+6.77%
Current month+11.12%
1 month+21.93%
3 months+29.34%
6 months+25.19%
Current year+33.22%
1 week 1,741
Extreme 1741
1,909.9
1 month 1,530
Extreme 1530
1,909.9
Current year 1,391.8
Extreme 1391.8
1,909.9
1 year 1,251.6
Extreme 1251.6
1,909.9
3 years 775.05
Extreme 775.05
1,909.9
5 years 669.8
Extreme 669.8
1,909.9
10 years 200
Extreme 200
1,909.9
Manager TitleAgeSince
Chief Executive Officer 53 01/04/2023
Chief Executive Officer 70 01/04/2023
Chief Tech/Sci/R&D Officer 52 16/10/2023
Director TitleAgeSince
Chairman 79 05/07/2012
Director/Board Member 53 11/11/2008
Director/Board Member 70 01/08/1994
Date Insider Type Main position Quantity % Market Cap.
19/12/24Sell 4,000,000 1.5766%
Change 5-day change 1-year change 3-year change Capi.($)
+0.65%+6.77%+29.31%+140.27% 4.95B
+0.35%-4.87%+49.87%+157.34% 1,031B
-2.69%-6.22%+59.19%+54.51% 595B
-0.27%-3.41%+30.97%+79.48% 431B
-0.61%-2.27%+27.99%+22.26% 326B
-0.35%-2.22%+27.78%+43.12% 277B
-0.95%-6.71%+19.38%+22.14% 263B
+0.42%+3.67%-23.45%-38.08% 224B
+0.86%-2.63%+22.50%+57.55% 193B
+1.28%-3.03%+20.76%+70.62% 164B
Average +0.54%-2.76%+26.43%+60.92% 350.92B
Weighted average by Cap. +0.81%-4.29%+35.49%+76.61%

Financials

2027 *2028 *
Net sales 108B 1.12B 978M 903M 830M 1.57B 1.6B 10.78B 4.23B 52.63B 4.2B 4.11B 181B 120B 1.25B 1.09B 1.01B 925M 1.75B 1.78B 12.02B 4.71B 58.69B 4.69B 4.58B 202B
Net income 14B 145M 127M 117M 108M 204M 208M 1.4B 550M 6.84B 546M 534M 23.59B 16.7B 174M 152M 140M 129M 244M 248M 1.67B 656M 8.16B 652M 637M 28.13B
Net Debt -11.82B -123M -107M -99.11M -91.11M -173M -176M -1.18B -464M -5.78B -461M -451M -19.92B -23.66B -246M -215M -198M -182M -345M -351M -2.37B -929M -11.56B -923M -903M -39.86B
Logo Ipca Laboratories Limited
Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The Company’s products are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing APIs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc. and Ipca Pharma Nigeria Ltd.
Employees
17,210
Date Price Change Volume
16/07/26 1,890.20 +0.65% 794,803
15/07/26 ₹1,878.00 +2.04% 291,486
14/07/26 ₹1,840.40 +0.94% 241,497
13/07/26 ₹1,823.30 +1.98% 341,668
10/07/26 ₹1,787.90 +0.99% 146,840
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
1,878.00INR
Average target price
1,733.50INR
Spread / Average Target
-7.69%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IPCALAB Stock